Mirum Pharmaceuticals (MIRM) Insider Trading & Ownership $39.59 +0.01 (+0.03%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.87%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$74,700.35Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$7.30 M Get MIRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Mirum Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MIRM Insider Buying and Selling by Quarter Remove Ads Mirum Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/17/2025Christopher PeetzCEOSell27,279$44.21$1,206,004.59 3/17/2025Jolanda HoweSVPSell57,606$44.35$2,554,826.10 3/17/2025Peter RadovichCOOSell7,879$44.21$348,330.59 3/4/2025Patrick J HeronDirectorBuy1,335$45.57$60,835.95 2/3/2025Christopher PeetzCEOSell9,102$48.22$438,898.44 2/3/2025Jolanda HoweSVPSell1,064$48.22$51,306.08 2/3/2025Peter RadovichCOOSell2,627$48.22$126,673.94 1/24/2025Christopher PeetzCEOSell6,837$47.92$327,629.04 1/24/2025Jolanda HoweSVPSell902$47.92$43,223.84 1/24/2025Peter RadovichCOOSell3,177$47.92$152,241.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/17/2025Joanne QuanInsiderSell6,969$45.86$319,598.34 1/7/2025Christopher PeetzCEOSell7,489$42.82$320,678.98 1/7/2025Jolanda HoweSVPSell750$42.82$32,115.00 1/7/2025Peter RadovichCOOSell1,998$42.82$85,554.36 11/14/2024Jolanda HoweSVPSell2,500$47.10$117,750.00 9/18/2024Patrick J HeronDirectorBuy115$37.40$4,301.00 9/6/2024Patrick J HeronDirectorBuy230$41.58$9,563.40 7/2/2024Jolanda HoweSVPSell375$34.00$12,750.00 6/24/2024Pamela VigInsiderSell30,559$34.00$1,039,006.00 6/5/2024Saira RamasastryDirectorSell5,000$25.68$128,400.00 (Data available from 1/1/2013 forward) MIRM Insider Trading Activity - Frequently Asked Questions Who is on Mirum Pharmaceuticals's Insider Roster? The list of insiders at Mirum Pharmaceuticals includes Christopher Peetz, Eric Bjerkholt, James E Flynn, Joanne Quan, Jolanda Howe, Lara Longpre, Michael G. Grey, Niall O'donnell, Pamela Vig, Patrick J Heron, Peter Radovich, and Saira Ramasastry. Learn more on insiders at MIRM. What percentage of Mirum Pharmaceuticals stock is owned by insiders? 22.87% of Mirum Pharmaceuticals stock is owned by insiders. Learn more on MIRM's insider holdings. Which Mirum Pharmaceuticals insiders have been buying company stock? The following insiders have purchased MIRM shares in the last 24 months: Eric Bjerkholt ($397,700.00), and Patrick J Heron ($4,101,480.20). How much insider buying is happening at Mirum Pharmaceuticals? Insiders have purchased a total of 168,358 MIRM shares in the last 24 months for a total of $4,499,180.20 bought. Which Mirum Pharmaceuticals insiders have been selling company stock? The following insiders have sold MIRM shares in the last 24 months: Christopher Peetz ($2,580,243.02), Joanne Quan ($319,598.34), Jolanda Howe ($3,041,225.11), Lara Longpre ($54,325.36), Michael G. Grey ($863,936.00), Pamela Vig ($1,039,006.00), Peter Radovich ($899,835.62), and Saira Ramasastry ($128,400.00). How much insider selling is happening at Mirum Pharmaceuticals? Insiders have sold a total of 228,940 Mirum Pharmaceuticals shares in the last 24 months for a total of $8,926,569.45 sold. Mirum Pharmaceuticals Key ExecutivesMr. Christopher Peetz (Age 45)Co-Founder, CEO and Director Compensation: $1.31M4 recent tradesMr. Peter Radovich M.B.A. (Age 46)Ph.D., COO & President Compensation: $881.8k4 recent tradesMr. Eric H. Bjerkholt M.B.A. (Age 64)Chief Financial Officer Compensation: $600.4kDr. Pamela Vig Ph.D. (Age 53)Chief Scientific Officer Compensation: $678.2kAndrew McKibbenVice President of Investor Relations and FinanceMr. Paul K. RossChief Compliance OfficerMs. Erin Campany (Age 56)Senior Vice President of Human Resources Ms. Lara Longpre MBA (Age 54)MSC, Chief Development Officer Compensation: $678.2kMs. Vinita P. KumarSenior vice President of QualityDr. Jean-Luc Girardet Ph.D.Senior Vice President of Technical Operations More Insider Trading Tools from MarketBeat Related Companies Roivant Sciences Insider Trading Lantheus Insider Trading TG Therapeutics Insider Trading Revolution Medicines Insider Trading BridgeBio Pharma Insider Trading Blueprint Medicines Insider Trading Sarepta Therapeutics Insider Trading Axsome Therapeutics Insider Trading Krystal Biotech Insider Trading Nuvalent Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market This page (NASDAQ:MIRM) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MIRM Stock Free MIRM Stock Alerts